Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CLOV
CLOV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLOV News
Clover Health Partners with Kno2 for Real-Time Data Interoperability
6d ago
Newsfilter
United Airlines and Clover Health Options Trading Active
Feb 27 2026
NASDAQ.COM
CLOVER HEALTH INVESTMENTS CORP: UBS Lowers Price Target to $2.75 from $3
Feb 27 2026
moomoo
Clover Health (CLOV) Q4 2025 Earnings Transcript
Feb 27 2026
NASDAQ.COM
Clover Health Reports Strong 2025 Earnings and Growth Outlook
Feb 27 2026
seekingalpha
Clover Health Projects 2026 Revenue Above Consensus Estimates
Feb 26 2026
seekingalpha
Clover Health Q4 Earnings Beat Expectations, 2026 Guidance Optimistic
Feb 26 2026
seekingalpha
Clover Health Set to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Clover Health Stock Declines Due to Medicare Proposal
Jan 27 2026
Benzinga
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline
Jan 14 2026
Benzinga
Clover Health (CLOV) Expects First Full-Year GAAP Profitability with 53% Membership Growth
Jan 14 2026
Benzinga
Clover Health (CLOV) Reports 53% Membership Growth for 2026, Shares Up 11%
Jan 14 2026
seekingalpha
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
Jan 14 2026
Benzinga
Clover Health Reports 53% Medicare Advantage Growth, Aiming for GAAP Net Income Profitability in 2026
Jan 14 2026
Globenewswire
Clover Health (CLOV) Achieves 53% Medicare Advantage Growth, Targeting First GAAP Net Income Profitability in 2026
Jan 14 2026
Newsfilter
Counterpart Health Reports Key 2025 Highlights, Clinician Adoption Up 450%
Jan 12 2026
Globenewswire
Show More News
